3.23 USD
0 (0%)
Overall NHTC gets a fundamental rating of 3 out of 10. We evaluated NHTC against 36 industry peers in the Personal Care Products industry. While NHTC has a great health rating, there are worries on its profitability. NHTC does not seem to be growing, but still is valued expensively. NHTC also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
NHTC had negative earnings in the past year.
In the past year NHTC has reported a negative cash flow from operations.
Each year in the past 5 years NHTC has been profitable.
In multiple years NHTC reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a Return On Assets value of -0.28%, NHTC perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
Looking at the Return On Equity, with a value of -0.45%, NHTC is in line with its industry, outperforming 52.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.28% | ||
| ROE | -0.45% | ||
| ROIC | N/A |
ROA(3y)0.74%
ROA(5y)0.82%
ROE(3y)1.23%
ROE(5y)1.35%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NHTC's Profit Margin has declined in the last couple of years.
The Gross Margin of NHTC (73.87%) is better than 75.00% of its industry peers.
NHTC's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for NHTC so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 73.87% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-10.12%
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
NHTC does not have a ROIC to compare to the WACC, probably because it is not profitable.
NHTC has about the same amout of shares outstanding than it did 1 year ago.
NHTC has more shares outstanding than it did 5 years ago.
There is no outstanding debt for NHTC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
NHTC has an Altman-Z score of 1.77. This is a bad value and indicates that NHTC is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.77, NHTC is doing worse than 61.11% of the companies in the same industry.
There is no outstanding debt for NHTC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.77 |
ROIC/WACCN/A
WACC8.78%
2.3 Liquidity
NHTC has a Current Ratio of 2.57. This indicates that NHTC is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of NHTC (2.57) is better than 66.67% of its industry peers.
NHTC has a Quick Ratio of 2.42. This indicates that NHTC is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.42, NHTC is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.57 | ||
| Quick Ratio | 2.42 |
3. Growth
3.1 Past
NHTC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -114.29%.
NHTC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.90% yearly.
NHTC shows a decrease in Revenue. In the last year, the revenue decreased by -5.07%.
Measured over the past years, NHTC shows a very negative growth in Revenue. The Revenue has been decreasing by -11.15% on average per year.
EPS 1Y (TTM)-114.29%
EPS 3Y-17.9%
EPS 5YN/A
EPS Q2Q%-1309.68%
Revenue 1Y (TTM)-5.07%
Revenue growth 3Y-10.54%
Revenue growth 5Y-11.15%
Sales Q2Q%-11.32%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for NHTC. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NHTC has a Yearly Dividend Yield of 25.97%, which is a nice return.
In the last 3 months the price of NHTC has falen by -25.32%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
NHTC's Dividend Yield is rather good when compared to the industry average which is at 2.06. NHTC pays more dividend than 100.00% of the companies in the same industry.
NHTC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 25.97% |
5.2 History
The dividend of NHTC has a limited annual growth rate of 4.44%.
NHTC has been paying a dividend for at least 10 years, so it has a reliable track record.
NHTC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years10
5.3 Sustainability
The earnings of NHTC are negative and hence is the payout ratio. NHTC will probably not be able to sustain this dividend level.
DP-7807.63%
EPS Next 2YN/A
EPS Next 3YN/A
NASDAQ:NHTC (12/30/2025, 11:21:40 AM)
3.23
0 (0%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners12.29%
Inst Owner Change-13.94%
Ins Owners15.6%
Ins Owner Change0%
Market Cap37.18M
Revenue(TTM)40.87M
Net Income(TTM)-118.00K
Analysts0
Price TargetN/A
Short Float %0.72%
Short Ratio0.92
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 25.97% |
Yearly Dividend0.8
Dividend Growth(5Y)4.44%
DP-7807.63%
Div Incr Years0
Div Non Decr Years10
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.91 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.42 | ||
| P/tB | 1.42 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.43
OCFYN/A
SpS3.55
BVpS2.27
TBVpS2.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.28% | ||
| ROE | -0.45% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 73.87% | ||
| FCFM | N/A |
ROA(3y)0.74%
ROA(5y)0.82%
ROE(3y)1.23%
ROE(5y)1.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-10.12%
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y-0.03%
F-Score3
Asset Turnover0.97
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 70.34% | ||
| Cap/Sales | 0.2% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.57 | ||
| Quick Ratio | 2.42 | ||
| Altman-Z | 1.77 |
F-Score3
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)47.19%
Cap/Depr(5y)53.89%
Cap/Sales(3y)0.17%
Cap/Sales(5y)0.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-114.29%
EPS 3Y-17.9%
EPS 5YN/A
EPS Q2Q%-1309.68%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.07%
Revenue growth 3Y-10.54%
Revenue growth 5Y-11.15%
Sales Q2Q%-11.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-42.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-52.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.38%
OCF growth 3YN/A
OCF growth 5YN/A
NATURAL HEALTH TRENDS CORP / NHTC FAQ
What is the fundamental rating for NHTC stock?
ChartMill assigns a fundamental rating of 3 / 10 to NHTC.
Can you provide the valuation status for NATURAL HEALTH TRENDS CORP?
ChartMill assigns a valuation rating of 0 / 10 to NATURAL HEALTH TRENDS CORP (NHTC). This can be considered as Overvalued.
What is the profitability of NHTC stock?
NATURAL HEALTH TRENDS CORP (NHTC) has a profitability rating of 2 / 10.
How financially healthy is NATURAL HEALTH TRENDS CORP?
The financial health rating of NATURAL HEALTH TRENDS CORP (NHTC) is 7 / 10.